Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-05-17T11:49:47+0100
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
I'm a little template short and blank. I link to void and keep hidden out.
2024-05-17T11:49:47+0100
How to trade Walt Disney shares ahead of their Q2 earnings amid activist interest and cost cutting.
2024-05-02T13:14:03+0100
Expanding Consumer Spending in Key Categories.
2024-04-22T16:25:08+0100
easyJet’s trading update saw losses fall over the winter, leaving investors looking to a strong summer performance.
2024-04-19T16:29:35+0100
The first-quarter trading statement from Ocado has seen strong volume growth and market share gains for the logistics and delivery business. Volumes grew 8.1% year-on-year, driving Q1 retail revenue growth of 10.6%, to £645.3m.
2024-03-26T12:58:31+0000
Aquis-listed Incanthera PLC is moving fast as it announces a commercial deal for its high-end skincare range, Skin + CELL.
2024-03-25T13:19:03+0000
Alongside what building supplies company Wicks says was a "robust" set of full-year results it has confirmed it will be acquiring a 51% stake in the parent company of Solar Fast.
2024-03-19T11:09:42+0000
The success of the recent drilling program in Colombia has seen shares rise more than 40% in the last few weeks alone. Arrow Exploration's Marshall Abbott, says the company is one of only a handful of such AIM share performances.
2024-03-14T15:24:12+0000
The company, a spin-off from GSK in the summer of 2022, punched back up above its listing price of 335p in a strong 7% move after good full-year earnings.
2024-02-29T09:29:25+0000